Gray Matter Alterations in Psychosis Linked to Molecular Features

Josh Bernstock, MD, PhD, MPH, a neurosurgeon-scientist and entrepreneur affiliated with Texas Children’s Hospital, Baylor College of Medicine, and MD Anderson, is one of Centile Bioscience's co-founders. As Chief Medical Officer, he guides the company's clinical direction, ensuring its technology delivers practical value in clinical care, drug development, and research.

Hannah Mamuszka, a health-economics leader and diagnostics expert, joined Centile Bioscience's Advisory Board, where she guides the company's market-access, reimbursement, and health-economics strategy as Centile's platform moves toward clinical and commercial use.

Centile Bioscience was founded to carry a body of award-winning brain science into practice. Its founding research, "Brain charts for the human lifespan," was published in Nature and won the inaugural FASEB/NIH DataWorks! Grand Prize, one of only two Grand Prize awards selected from more than 100 competing research groups nationwide.